Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001477932-24-008021
Filing Date
2024-12-11
Accepted
2024-12-11 20:58:34
Documents
1
Period of Report
2024-12-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 4917
  Complete submission text file 0001477932-24-008021.txt   6433
Mailing Address C/O ASP ISOTOPES INC. 601 PENNSYLVANIA AVENUE NW, SUITE 900 WASHINGTON, DC DC 20004
Business Address
Moore Duncan (Reporting) CIK: 0001888265 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41555 | Film No.: 241543010

Mailing Address 1101 PENNSYLVANIA AVENUE NW SUITE 300 WASHINGTON DC 20004
Business Address 1101 PENNSYLVANIA AVENUE NW SUITE 300 WASHINGTON DC 20004 202-756-2245
ASP Isotopes Inc. (Issuer) CIK: 0001921865 (see all company filings)

EIN.: 872618235 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2890 Miscellaneous Chemical Products
(CF Office: 08 Industrial Applications and Services)